Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and children over the age of 6. Although atomoxetine is only FDA approved for the treatment of ADHD, it is sometimes used off-label for the treatment of adult patients with treatment-resistant depression. This activity outlines the indications, mechanism of action, safe administration, adverse effects, contraindications, and monitoring of atomoxetine.
